Literature DB >> 7705772

Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture.

A Mallat1, A M Preaux, S Blazejewski, J Rosenbaum, D Dhumeaux, P Mavier.   

Abstract

During the course of ongoing liver fibrogenesis, Ito cells acquire myofibroblastic features, proliferate, and synthesize increased amounts of extracellular matrix components. Interferon (IFN) alfa and IFN gamma have been shown to elicit antiproliferative and/or antifibrogenic effects in various cell cultures of mesenchymal origin. The aim of this study was to investigate the effects of IFN-alpha and IFN-gamma on cultured human myofibroblastic Ito cells (MFBIC) proliferation and collagen synthesis and secretion. Serum-stimulated incorporation of [3H]-thymidine into DNA of MFBIC was dose-dependently decreased by both cytokines. IFN-alpha (10(4) U/mL) and IFN-gamma (10(3) U/mL) decreased DNA synthesis by 69% and 66%, respectively. Inhibition of cell proliferation was confirmed by cell counting. Similar results were observed when cell growth was stimulated with platelet-derived growth factor (PDGF-BB, PDGF-AA) or transforming growth factor (TGF)-beta 1. Collagen secretion per cell was inhibited by both cytokines, as assessed by [3H]-hydroxyproline incorporation. After a 6-day treatment, IFN-gamma showed a greater potency than IFN-alpha in inhibiting secretion of newly synthetized collagen (41% and 4% of control in the presence of 10(2) U/mL of IFN-gamma and 10(4) U/mL of IFN-alpha, respectively). Both IFN-alpha and IFN-gamma concurrently decreased steady-state expression of type I and type III procollagen messenger RNAs (mRNAs) in quiescent MFBIC. Viability assays ruled out cytotoxic effects of the two molecules. Finally, both IFNs decreased smooth muscle alpha-actin (SM alpha-actin) expression, whether assayed by immunoblotting or by Northern blot analysis. We conclude that IFN-alpha and IFN-gamma inhibit proliferation as well as collagen synthesis in human MFBIC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705772

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

Review 1.  Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.

Authors:  Y Inagaki; I Okazaki
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Effects of salvianolic acid-A on NIH/3T3 fibroblast proliferation, collagen synthesis and gene expression.

Authors:  Cheng-Hai Liu; Yi-Yang Hu; Xiao-Ling Wang; Ping Liu; Lie-Ming Xu
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

3.  Seropharmalogical effects of Fuzheng Huayu decoction on rat Ito cell morphology and function in culture.

Authors:  C H Liu; C Liu; P Liu; L M Xu
Journal:  World J Gastroenterol       Date:  1997-12-15       Impact factor: 5.742

4.  Adeno-associated virus mediated interferon-gamma inhibits the progression of hepatic fibrosis in vitro and in vivo.

Authors:  Miao Chen; Guang-Ji Wang; Yong Diao; Rui-An Xu; Hai-Tang Xie; Xin-Yan Li; Jian-Guo Sun
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

5.  Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene.

Authors:  A J Dessein; D Hillaire; N E Elwali; S Marquet; Q Mohamed-Ali; A Mirghani; S Henri; A A Abdelhameed; O K Saeed; M M Magzoub; L Abel
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

6.  Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells.

Authors:  Tomohiro Ogawa; Norifumi Kawada; Kazuo Ikeda
Journal:  Hepatol Int       Date:  2009-04-21       Impact factor: 6.047

Review 7.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

8.  Regulatory role of interleukin-10 and interferon-gamma in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum.

Authors:  Violaine Arnaud; Jun Li; Yuanyuan Wang; Xiao Fu; Shi Mengzhi; Xinsong Luo; Xunya Hou; Helia Dessein; Zhou Jie; Yu Xin-Ling; Hongbin He; Donald P McManus; Yuesheng Li; Alain Dessein
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

9.  Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment.

Authors:  J F Dufour; R DeLellis; M M Kaplan
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

10.  No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection.

Authors:  Carole Eboumbou Moukoko; Nasureldin El Wali; O K Saeed; Qurashi Mohamed-Ali; Jean Gaudart; Alain J Dessein; Christophe Chevillard
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.